We are live on ! Find out more
GC

Gratry & Company Portfolio holdings

AUM $72.2M
1-Year Est. Return 19.87%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$23.7M
Cap. Flow
-$30.5M
Cap. Flow %
-11.99%
Top 10 Hldgs %
34.9%
Holding
66
New
3
Increased
5
Reduced
51
Closed
3

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$7.41M
2
PUK icon
Prudential
PUK
+$5.42M
3
SAN icon
Banco Santander
SAN
+$1.43M
4
GMK
GRUMA SAB DE C V ADS(RP 4 B SHS
GMK
+$173K
5
ERIC icon
Ericsson
ERIC
+$126K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$8.11M
2
AZ
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
+$7.41M
3
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$6.24M
4
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$3.78M
5
NXPI icon
NXP Semiconductors
NXPI
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 17.25%
2 Industrials 12.47%
3 Financials 10.02%
4 Consumer Discretionary 9.27%
5 Technology 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXPI icon
1
NXP Semiconductors
NXPI
$67.5B
$12.8M 5.02%
192,666
-30,199
-14% -$1.85M
LYB icon
2
LyondellBasell Industries
LYB
$19.6B
$8.96M 3.53%
91,787
-10,628
-10% -$1.01M
NVO
3
Novo Nordisk
NVO
$219B
$8.8M 3.47%
381,268
-51,810
-12% -$1.14M
BAY
4
DELISTED
BAYER AG SPONS ADR
BAY
$8.58M 3.38%
60,707
-7,609
-11% -$1.07M
ETN icon
5
Eaton
ETN
$156B
$8.5M 3.34%
110,089
-10,387
-9% -$771K
SLB icon
6
SLB Ltd
SLB
$69.4B
$8.48M 3.34%
+71,920
New +$7.41M
APTV icon
7
Aptiv
APTV
$12.1B
$8.32M 3.27%
120,985
-10,150
-8% -$689K
NVS icon
8
Novartis
NVS
$285B
$8M 3.15%
98,612
-11,150
-10% -$877K
CB icon
9
Chubb
CB
$137B
$8M 3.15%
77,102
-7,019
-8% -$719K
DT
10
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$7.8M 3.07%
445,496
-45,363
-9% -$795K
CBI
11
DELISTED
Chicago Bridge & Iron Nv
CBI
$7.72M 3.04%
113,159
-21,419
-16% -$1.7M
ING icon
12
ING
ING
$92B
$7.71M 3.04%
550,058
-49,585
-8% -$698K
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$15.3B
$7.64M 3.01%
51,978
-2,242
-4% -$311K
TM icon
14
Toyota
TM
$211B
$7.63M 3%
63,723
-4,646
-7% -$517K
AGN
15
DELISTED
Allergan plc
AGN
$7.28M 2.86%
32,615
-1,780
-5% -$369K
PUK icon
16
Prudential
PUK
$35.2B
$6.92M 2.72%
155,480
+122,168
+367% +$5.42M
NBIS
17
Nebius Group N.V.
NBIS
$46.4B
$6.54M 2.58%
183,578
-16,652
-8% -$511K
SDRL
18
DELISTED
Seadrill Limited Common Stock
SDRL
$6.43M 2.53%
601
-27
-4% -$264K
NGG icon
19
National Grid
NGG
$82B
$6.35M 2.5%
88,434
-7,442
-8% -$515K
PNR icon
20
Pentair
PNR
$10B
$6.24M 2.45%
128,731
-11,421
-8% -$581K
HIT
21
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$6.23M 2.45%
84,887
-4,834
-5% -$355K
DEO icon
22
Diageo
DEO
$47.2B
$6.16M 2.42%
48,377
-4,065
-8% -$512K
TEL icon
23
TE Connectivity
TEL
$59.3B
$5.43M 2.14%
87,896
-11,469
-12% -$687K
MLCO icon
24
Melco Resorts & Entertainment
MLCO
$2.13B
$5.38M 2.12%
150,689
-10,715
-7% -$370K
WX
25
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$2.66M 1.05%
81,071
-110,474
-58% -$3.78M
1
2 3

Similar funds

T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
DCM
Delpha Capital Management New York $72.9M AUM
XS
XML Securities Bethesda, Maryland $80.6M AUM
BSCP
Bay Street Capital Partners New York $81.9M AUM
SCM
Stonerise Capital Management San Francisco, California $62.6M AUM 1.3% 1-Year Est. Return
FMA
FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return
MSTVIM
Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return
LA
Lucus Advisors New York $57.7M AUM 0.6% 1-Year Est. Return

Gratry & Company's Q2 2014 Portfolio in Review

As of Q2 2014, Gratry & Company held 66 positions worth $254M, down 8.5% from $278M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Gratry & Company withdrew a net $30.5M in Q2 2014, closing 3 positions and reducing 51 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $8.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

Against the trend, Gratry & Company opened a new position in SLB Ltd worth $8.48M.

  • Gratry & Company's largest Q2 2014 buy was SLB Ltd: 71,920 shares worth $8.48M.
  • Gratry & Company added most to Prudential in Q2 2014, an estimated $5.42M increase.
  • Gratry & Company's biggest Q2 2014 reduction was WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS, cutting an estimated $3.78M.
  • Gratry & Company fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $8.11M.
  • Gratry & Company's ten largest holdings make up 35% of its $254M portfolio in Q2 2014.
  • Gratry & Company opened 3 new positions and closed 3 in Q2 2014.
  • Gratry & Company's portfolio value fell 8.5% quarter-over-quarter to $254M.

Based on Gratry & Company's 13F filing for Q2 2014, filed 31 Jul 2014.